We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.6B
AUM Growth
+$1.35B
Cap. Flow
+$272M
Cap. Flow %
1.74%
Top 10 Hldgs %
17.46%
Holding
2,121
New
637
Increased
418
Reduced
436
Closed
588

Sector Composition

Rank Sector Weight
1 Healthcare 24.06%
2 Consumer Discretionary 14.39%
3 Financials 10.11%
4 Technology 9.6%
5 Industrials 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APA icon
1501
APA Corp
APA
$12.3B
$129K ﹤0.01%
+13,648
New +$187K
ABEV icon
1502
Ambev
ABEV
$47.4B
$126K ﹤0.01%
+55,639
New +$140K
CASA
1503
DELISTED
Casa Systems, Inc. Common Stock
CASA
$121K ﹤0.01%
+29,922
New +$140K
CAN
1504
Canaan Creative
CAN
$192M
$117K ﹤0.01%
+62,795
New +$131K
LPG icon
1505
Dorian LPG
LPG
$1.88B
$112K ﹤0.01%
+13,929
New +$115K
CHU
1506
DELISTED
China Unicom (HONG KONG) Limited
CHU
$110K ﹤0.01%
16,784
-18,612
-53% -$122K
MDRX
1507
DELISTED
Veradigm Inc. Common Stock
MDRX
$108K ﹤0.01%
+13,275
New +$108K
GB.WS
1508
DELISTED
Global Blue Group Holding AG Warrants exercisable for one Ordinary Share of Global Blue Group Holding AG at a price of $11.50 per share
GB.WS
$107K ﹤0.01%
+167,896
New +$99.4K
TOIIW
1509
The Oncology Institute Warrant
TOIIW
$106K ﹤0.01%
+62,492
New +$103K
SGMO
1510
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$105K ﹤0.01%
+11,127
New +$120K
LUNA
1511
DELISTED
Luna Innovations Incorporated
LUNA
$102K ﹤0.01%
17,045
-2,140
-11% -$12.7K
LMRK
1512
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
$100K ﹤0.01%
+11,033
New +$109K
AKBA icon
1513
Akebia Therapeutics
AKBA
$343M
$97K ﹤0.01%
38,578
-322,389
-89% -$2.83M
CSPR
1514
DELISTED
Casper Sleep Inc.
CSPR
$97K ﹤0.01%
+13,456
New +$112K
DNOW icon
1515
DNOW Inc
DNOW
$2.59B
$95K ﹤0.01%
+20,959
New +$159K
DBVT
1516
DBV Technologies
DBVT
$823M
$80K ﹤0.01%
4,593
GMLP
1517
DELISTED
Golar LNG Partners LP
GMLP
$76K ﹤0.01%
37,469
DMYT.WS
1518
DELISTED
dMY Technology Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Clas
DMYT.WS
$75K ﹤0.01%
+24,999
New +$55.9K
SIGA icon
1519
SIGA Technologies
SIGA
$222M
$69K ﹤0.01%
+10,113
New +$68.7K
EXTN
1520
DELISTED
Exterran Corporation
EXTN
$67K ﹤0.01%
16,052
-353
-2% -$1.76K
MBIO icon
1521
Mustang Bio
MBIO
$4.24M
$66K ﹤0.01%
+28
New +$69K
QUAD icon
1522
Quad
QUAD
$438M
$62K ﹤0.01%
20,615
NSCO.WS
1523
DELISTED
Nesco Holdings, Inc. Warrants, exerciseable for Common Stock
NSCO.WS
$50K ﹤0.01%
166,665
LGVW.WS
1524
DELISTED
Longview Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Clas
LGVW.WS
$49K ﹤0.01%
+49,997
New +$55.8K
GLOP
1525
DELISTED
GASLOG PARTNERS LP
GLOP
$48K ﹤0.01%
+14,273
New +$56.5K

Similar funds

Marshall Wace's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace held 2,121 positions worth $15.6B, up 9.5% from $14.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q3 2020 filing shows 637 new, 418 increased, 436 reduced and 588 closed positions. Its largest new stake was Keurig Dr Pepper: 2,859,399 shares worth $78.9M. The largest sale was Alibaba, an estimated $170M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q3 2020 buy was Keurig Dr Pepper: 2,859,399 shares worth $78.9M.
  • Marshall Wace added most to Alphabet (Google) Class A in Q3 2020, an estimated $208M increase.
  • Marshall Wace's biggest Q3 2020 reduction was Alibaba, cutting an estimated $170M.
  • Marshall Wace fully exited Procter & Gamble in Q3 2020, selling an estimated $139M.
  • Marshall Wace's ten largest holdings make up 17% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace opened 637 new positions and closed 588 in Q3 2020.
  • Marshall Wace's portfolio value rose 9.5% quarter-over-quarter to $15.6B.

Based on Marshall Wace's 13F filing for Q3 2020, filed 16 Nov 2020.